The discovery of effective drugs for the treatment of neurodegenerative disorders (NDs) is a
deadlock. Due to their complex etiology and high heterogeneity, progresses in the …

Treatment of neurodegenerative diseases has become one of the most challenging topics of
the last decades due to their prevalence and increasing societal cost. The crucial point of the …

Alzheimer's disease (AD) is a chronic neurodegenerative disorder that accounts for about
60% of all diagnosed cases of dementia worldwide. Although there are currently several …

Nanomedicine is certainly one of the scientific and technological challenges of the coming
years. In particular, biodegradable nanoparticles formulated from poly (D, L-lactide-co …

The blood–brain barrier (BBB) acts as a barrier to prevent the central nervous system (CNS)
from damage by substances that originate from the blood circulation. The BBB limits drug …

Neurodegenerative diseases (NDs) such as Alzheimer's disease (AD) and Parkinson's
disease (PD) are an accelerating global health problem as life expectancy rises worldwide …

The blood-brain barrier (BBB), which protects the central nervous system (CNS) from
unnecessary substances, is a challenging obstacle in the treatment of CNS disease. Many …

Effective intervention is essential to combat the coming epidemic of neurodegenerative (ND)
diseases. Nanomedicine can overcome restrictions of CNS delivery imposed by the blood …

Aim: Nanoneuroscience, based on the use polymeric nanoparticles (NPs), represents an
emerging field of research for achieving an effective therapy for neurodegenerative …

Neurological disorders are an important global public health problem, but pharmaceutical
treatments are limited due to drug access to the central nervous system being restricted by …